Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 86Leukemia 50Gastrointestinal Stromal Tumors 41Leukemia, Myeloid, Chronic-Phase 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Blast Crisis 17Philadelphia Chromosome 13Brain Neoplasms 12Sarcoma 10Leukemia, Myeloid, Acute 10Glioblastoma 10Lung Neoplasms 9Leukemia, Myeloid, Accelerated Phase 9Gliosarcoma 9Prostatic Neoplasms 8Neoplasms 7Neoplasm Metastasis 7Glioma 7Oligodendroglioma 6Melanoma 6Leukemia, Myelomonocytic, Chronic 6Dermatofibrosarcoma 6Astrocytoma 6Small Cell Lung Carcinoma 5Recurrence 5Primary Myelofibrosis 5Polycythemia Vera 5Ovarian Neoplasms 5Leukemia, Myeloid 5Central Nervous System Neoplasms 5

Interventions

Oxaliplatin 14Fluorouracil 11Capecitabine 9Surveys and Questionnaires 8Leucovorin 8Irinotecan 8Cisplatin 8Bevacizumab 8Standard of Care 5Gemcitabine 5Drug Therapy 4S 1 (combination) 3Radiotherapy 3Nivolumab 3Interviews as Topic 3IFL protocol 3Educational Status 3Cyclophosphamide 3Colonoscopy 3Blood Specimen Collection 35,10-methylenetetrahydrofolic acid 3trebananib 2tivozanib 2pembrolizumab 2Taxes 2Remote Patient Monitoring 2Pemetrexed 2Panitumumab 2Ocoxin 2N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Neoplasms × Imatinib Mesylate × Clear all
NCT00867113 2018-03-14

Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)

Novartis

Phase 2 Completed
91 enrolled 11 charts
GastrointestinalSarcoma

Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡